Drug Type CAR-M |
Synonyms CAR-M(Carisma Therapeutics) |
Target |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors), Gene transference, Macrophage replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | US | 05 Nov 2024 | |
Hepatocellular Carcinoma | Preclinical | US | 05 Nov 2024 | |
Neoplasms | Discovery | US | 21 Mar 2022 |